OMINQ Secures Over $1 Million in New Purchase Orders from Prominent Bioscience Company
- Follows a $2.5 Million Purchase Order from a Major Retail Chain: Reinforcing OMNIQ’s role in transforming retail operations with innovative AI-driven solutions.
- 20-Year Partnership Milestone: These orders underscore the continuation of a two-decade-long relationship with a key bioscience customer.
-
Strategic Collaborations with Ingenico and SHVA: This announcement builds on recent agreements with new partners, enhancing OMNIQ’s global footprint and technological
offerings.
SALT LAKE CITY, Sept. 11, 2024 (GLOBE NEWSWIRE) -- OMNIQ Corp. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a leading provider of AI-based technology solutions, today announced the receipt of new purchase orders totaling over $1 million from a long-term bioscience customer with whom it has maintained a strategic partnership for over two decades. These orders represent the latest phase in the customer’s technological refresh, including the replacement of legacy equipment and the introduction of cutting-edge scanning technology.
This development underscores OMNIQ’s continuing commitment to providing innovative solutions tailored to the evolving needs of its clients in the bioscience sector. The recent purchase includes the deployment of advanced scanners designed to enhance operational efficiency and accuracy, aligning with the customer's focus on staying at the forefront of bioscience innovation. In addition to refreshing equipment, the customer has seen notable growth, requiring them to purchase additional units.
Shai Lustgarten, CEO of OMNIQ, commented, “We are honored by the continued trust and confidence placed in us by our long-standing partner. This significant purchase order highlights the strength of our 20-year relationship and our commitment to delivering state-of-the-art technologies that support the critical work of the bioscience industry. As our partner embarks on a new phase of innovation, we are proud to contribute to their success with advanced scanning solutions.”
OMNIQ’s AI-driven products and solutions have a proven track record in optimizing operational processes across a variety of industries, including healthcare, logistics, and bioscience. The newly introduced equipment will provide the bioscience company with enhanced data capture capabilities, greater accuracy, and increased processing speeds—critical factors in maintaining high performance and regulatory compliance in the bioscience sector.